Mori, Ryutaro
Yoshida, Kazuhiro
Futamura, Manabu
Suetsugu, Tomonari
Shizu, Kaoru
Tanahashi, Toshiyuki
Tanaka, Yoshihiro
Matsuhashi, Nobuhisha
Yamaguchi, Kazuya
Funding for this research was provided by:
Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology (16K10496)
Taiho Pharmaceutical Co., Ltd.
Article History
Received: 5 July 2018
Accepted: 22 September 2018
First Online: 1 October 2018
Compliance with ethical standards
:
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Kazuhiro Y. has received grants and personal fees and honoraria from Taiho Pharmaceutical Co., Ltd., and had a consultant or advisory relationship with Taiho Pharmaceutical Co., Ltd. Outside of the submitted work, Kazuhiro Y. has received grants and personal fees from Pfizer Inc., Chugai Pharmaceutical Co., Ltd., and Yakult Honsha Co., Ltd.; grants from Bristol-Myers Squibb and Kyowa Hakko Kirin Co., Ltd.; honoraria from Pfizer Inc., Chugai Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., and Yakult Honsha Co., Ltd., and had a consultant or advisory relationship with La Roche, Ltd. All of the remaining authors declare that they have no conflicts of interest.